Pressure-enabled Retrograde Occlusive Therapy With Embolization for Control of Thyroid Disease (PROTECT Registry): A Multicenter Registry

Enrolling by invitationOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

April 1, 2027

Study Completion Date

April 1, 2028

Conditions
Hyperthyroidism; GoiterMultinodular GoiterThyroid NodulesThyroid DiseaseHyperthyroidismToxic Multinodular Goiter
Interventions
OTHER

Data Collection

Subjects with planned PED-TAE delivered via TriNav will receive their treatment following routine standard of care procedures. Post-procedural data obtained by a patient chart review will be collected in a study database. No additional study-specific interventions or visits outside of the routine clinical treatment will be performed.

Trial Locations (1)

34239

Sarasota Memorial Health Care System, Sarasota

All Listed Sponsors
collaborator

TriSalus Life Sciences, Inc.

INDUSTRY

lead

Sarasota Memorial Health Care System

OTHER